Pricing Log in Create free account

AIM ImmunoTech Inc. (AIM) vs CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN)

AIM ImmunoTech Inc. and CollPlant Biotechnologies Ltd. Sponsored ADR are both Biotechnology companies. AIM ImmunoTech Inc. and CollPlant Biotechnologies Ltd. Sponsored ADR are of similar size ($7.0M and $6.8M). AIM ImmunoTech Inc. grew revenue faster over the last twelve months: −21.5% against −86.8%. CollPlant Biotechnologies Ltd. Sponsored ADR has the higher net margin (−3,934.9% vs −15,021.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, AIM ImmunoTech Inc. leads on 8 and CollPlant Biotechnologies Ltd. Sponsored ADR on 8.

Valuation

Metric AIM CLGN Biotechnology median
P/E n/m n/m 8.50
P/S 30.63 16.34 9.71
P/B 0.38 1.76 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.69 n/m 0.64
EV/Sales (69.58) 24.21 9.21
Earnings yield (1,718.41%) (263.11%) (33.15%)
Free cash flow yield (502.43%) (216.45%) (25.50%)

Profitability

Metric AIM CLGN Biotechnology median
Gross margin (23.16%) (321.70%) 65.16%
Operating margin (11,724.21%) (3,900.94%) 0.00%
Net margin (15,021.05%) (3,934.91%) 0.00%
Free cash flow margin (15,385.26%) (3,522.64%) 0.00%
Return on equity (2,382.30%) (161.98%) (56.36%)
Return on assets (169.28%) (101.59%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AIM CLGN Biotechnology median
Revenue growth (TTM) (21.49%) (86.76%) 6.02%
EPS growth (last fiscal year) 72.19% 35.17% 30.26%
Revenue growth, 5-year CAGR (11.60%) (17.32%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AIM CLGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.11 1.57 4.72
Net debt to EBITDA 0.22 0.56 0.96

Dividend

Metric AIM CLGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AIM CLGN Biotechnology median
Market cap 6.79m 6.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack